NIH-funded research R21 grant

Identifying biomarkers for diarrhea-predominant irritable bowel syndrome using stool samples

Official title: Profiling diarrhea-predominant irritable bowel syndrome (IBS-D) using stool-based RNAs

Funded at Columbia University Health Sciences · NIH-11013340 · Data updated 2026-11-12

This study is looking to make it easier to diagnose diarrhea-predominant irritable bowel syndrome (IBS-D) by checking stool samples for certain markers, so if you have IBS-D, researchers want to find a simple and non-invasive way to help identify your condition better.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 19, 2024
Project endNovember 30, 2025
Funding year2025
Award (this year)$199,456
NIH project number5R21AI183029-02
Project IDNIH-11013340 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who experience symptoms of diarrhea-predominant irritable bowel syndrome.

Less likely to help

Patients with other gastrointestinal disorders or those under 21 years old may not benefit from this research.

What this research studies

This research aims to improve the diagnosis of diarrhea-predominant irritable bowel syndrome (IBS-D) by analyzing stool samples for specific RNA biomarkers. The approach involves sequencing RNA from exfoliated gut cells and studying the gut microbiome to identify changes associated with IBS-D. By comparing these findings in patient cohorts against healthy individuals, the researchers hope to develop a non-invasive method for diagnosing and classifying IBS-D, which currently lacks reliable diagnostic tests.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and non-invasive diagnostic methods for patients suffering from IBS-D.

How similar studies have gone: Previous research has shown promise in using stool-based biomarkers for gastrointestinal conditions, suggesting potential success for this novel approach.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Wang, Harris H — Columbia University Health Sciences
  • Study coordinator: Wang, Harris H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.